Radiopharmacy, radionanopharmacology and translational molecular imaging
RADIOMIN
![Foto de Radiopharmacy, radionanopharmacology and translational molecular imaging](/img/uploaded/110407a795194779b1a23220168ae072.jpg)
![Foto de University of Texas MD Anderson Cancer Center](/img/noimage_org.png)
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (1)
2019
-
Inhibitor of differentiation-1 sustains mutant KRAS-driven progression, maintenance, and metastasis of lung adenocarcinoma via regulation of a FOSL1 network
Cancer Research, Vol. 79, Núm. 3, pp. 625-638